NICOLE GERAGHTY: Open Payments
NPI 1427223494 · RONKONKOMA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,018 in 32 payments from 13 companies in 2025. Trend: 2023 $588 · 2024 $713 · 2025 $1,018
Food & beverage: $1,002Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $272 |
| Otsuka America Pharmaceutical, Inc. | 3 | $268 |
| Novo Nordisk Inc | 5 | $120 |
| ABBVIE INC. | 3 | $73 |
| Exact Sciences Corporation | 3 | $65 |
| Lilly USA, LLC | 2 | $55 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Ardelyx, Inc. | 1 | $23 |
Products named: REXULTI, LOKELMA, AIRSUPRA, VRAYLAR, MOUNJARO, Cologuard Collection Kit, BREZTRI, Auvelity.
Industry payments across NY — which companies pay providers there.
